• Vaccine Safety Control Elisa Test Kit for Erythromycin Residue
  • Vaccine Safety Control Elisa Test Kit for Erythromycin Residue
  • Vaccine Safety Control Elisa Test Kit for Erythromycin Residue
  • Vaccine Safety Control Elisa Test Kit for Erythromycin Residue

Vaccine Safety Control Elisa Test Kit for Erythromycin Residue

Environmental Protection: Yes
Certification: REACH
Color: White
Classification: Food Diagnostic
Function: Food Testing
Appearance: Liquid
Samples:
US$ 100/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Manufacturer/Factory & Trading Company
Gold Member Since 2022

Suppliers with verified business licenses

Beijing, China
Importers and Exporters
The supplier has import and export rights
Cooperated with Fortune 500
This supplier has Cooperated with Fortune 500 companies
Experienced Team
The supplier has 7 foreign trading staff(s) and 5 staff(s) with over 6 years of overseas trading experience
Self-branded
The supplier has 4 Self-brands, check the Audit Report for more information
to see all verified strength labels (28)
  • Overview
  • Product Description
  • Certifications
  • Company Profile
  • Contact Us
Overview

Basic Info.

Model NO.
KA03302H
Test Sample
Vaccine
Assay Time
1.5h
Detection Limit
0.2-16.2ng/Ml
Storage
2-8°c
Transport Package
Foam Box with Ice Bag
Specification
96 wells
Trademark
kwinbon
Origin
China
HS Code
38229000

Product Description

 
 
Product Description

1. Background
Erythromycin residue in the production of biological products may lead to abnormal reactions of human beings, thus strict MRLs have been established. This kit is a rapid test product for the determination of erythromycin residues which is sensitive, accurate and time-saving. It can considerably reduce the operation errors in the assay.
2. Test Principle
This ELISA kit is designed to detect erythromycin based on the principle of "indirect-competitive" enzyme immunoassay. The microtiter wells are coated with capture BSA-linked antigen. Erythromycin in the sample competes with antigen coated on the microtitre plate for the antibody. After the addition of enzyme conjugate, chromogenic substrate is used and the signal is measured by spectrophotometer. The absorption is inversely proportional to the erythromycin concentration in the sample.
3. Applications
This kit can be used in quantitative and qualitative analysis of erythromycin residue in biological samples.
 

Certifications

 

Vaccine Safety Control Elisa Test Kit for Erythromycin ResidueCertificate


ISO9001: 2008 & ISO13485: 2003; 

CNAS (China National Accreditation Service for Conformity Assessment); 

CQC (China Quauty Certification Center); 

CE (Communate Europpene).

 

Awards

High-Tech Enterprise;

Key High-Tech Enterprise of China Torch Program;

Beijing Engineering Research Center;

Industrialization Demonstration Project of China Torch Program;

Beijing Science and Technology Award;

Tianjin Science and Technology Award;

Shandong Science and Technology Award;
Company Profile

Vaccine Safety Control Elisa Test Kit for Erythromycin ResidueVaccine Safety Control Elisa Test Kit for Erythromycin ResidueVaccine Safety Control Elisa Test Kit for Erythromycin ResidueStuff

Kwinbon currently has more than 500 employees, including 18 doctors, 92 masters and 24 senior engineers. And also 46% of the employees are working on R&D.

Stock Market

NEEQ (National Equities Exchange and Quotations); Stock Code: 835044.

Facility

GMP (Good Manufacturing Practice) factory and SPF animal house. The cleanliness of producing department can reach above level 105.

Instruments

HPLC, GC, LC-MS/MS for test result calibration, which are expected to provide better quality control of our test products.
 

Contact Us

24 hours online

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
Number of Employees
274
Year of Establishment
2008-12-30